[18] [19] Side effects [edit] The most common side effects include gastrointestinal disorders, such as dyspepsia, decreased appetite, nausea, vomiting, abdominal pain, diarrhea
Eligibility for clinical trials typically requires: BMI of 30 or greater, or BMI of 27 or greater with weight-related comorbidities No recent use of other weight loss medications (washout periods apply) Willingness to attend regular study visits and follow protocols Meeting specific inclusion/exclusion criteria that vary by trial Compounding Pharmacies Some compounding pharmacies have begun offering retatrutide
It is unclear how retatrutide's glucagon component affects overall muscle composition at scale
Always cross-reference the opened date and storage conditions before attributing reduced response to your body's physiology
They will assess your medical history and determine if the medication is right for you.
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabete